APO Research
Talk to an analyst

APO RESEARCH · REPORT

Janus Kinase inhibitors (JAKi)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Janus Kinase inhibitors (JAKi) Industry Growth and Trends Forecast to 2032

28 December 202577 pages

Choose your research edition.

Industry ResearchJanus Kinase inhibitors (JAKi) Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Janus Kinase inhibitors (JAKi) Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Janus Kinase inhibitors (JAKi) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Janus Kinase inhibitors (JAKi) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Janus Kinase inhibitors (JAKi) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Janus Kinase inhibitors (JAKi) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Janus Kinase inhibitors (JAKi) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Janus Kinase inhibitors (JAKi) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Janus Kinase inhibitors (JAKi) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Janus Kinase inhibitors (JAKi) include Galapagos NV, AbbVie, Pfizer Inc. and Eli Lilly and Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Janus Kinase inhibitors (JAKi) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Janus Kinase inhibitors (JAKi) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Janus Kinase inhibitors (JAKi) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Janus Kinase inhibitors (JAKi).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Janus Kinase inhibitors (JAKi) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Janus Kinase inhibitors (JAKi) Market by Company

Galapagos NV

AbbVie

Pfizer Inc.

Eli Lilly and Co.

Janus Kinase inhibitors (JAKi) Segment by Type

Upadacitinib

Tofacitinib

Filgotinib

Baricitinib

Abrocitinib

Janus Kinase inhibitors (JAKi) Segment by Application

Hospital

Clinic

Other

Janus Kinase inhibitors (JAKi) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Janus Kinase inhibitors (JAKi) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Janus Kinase inhibitors (JAKi) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Janus Kinase inhibitors (JAKi).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Janus Kinase inhibitors (JAKi) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Janus Kinase inhibitors (JAKi) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Upadacitinib Table 2. Major Company of Tofacitinib Table 3. Major Company of Filgotinib Table 4. Major Company of Baricitinib Table 5. Major Company of Abrocitinib Table 6. Global Janus Kinase inhibitors (JAKi) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (K Units) Table 8. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Type (2021-2026) Table 9. Global Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (US$ Million) Table 10. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Type (2021-2026) Table 11. Global Janus Kinase inhibitors (JAKi) Price by Type (2021-2026) & (US$/Unit) Table 12. Global Janus Kinase inhibitors (JAKi) Sales by Type (2027-2032) & (K Units) Table 13. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Type (2027-2032) Table 14. Global Janus Kinase inhibitors (JAKi) Sales by Type (2027-2032) & (US$ Million) Table 15. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Type (2027-2032) Table 16. Global Janus Kinase inhibitors (JAKi) Price by Type (2027-2032) & (US$/Unit) Table 17. North America Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (K Units) Table 18. North America Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (K Units) Table 20. Europe Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (K Units) Table 24. Latin America Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (US$ Million) Table 27. Janus Kinase inhibitors (JAKi) Industry Trends Table 28. Janus Kinase inhibitors (JAKi) Industry Drivers Table 29. Janus Kinase inhibitors (JAKi) Industry Opportunities and Challenges Table 30. Janus Kinase inhibitors (JAKi) Industry Restraints Table 31. Global Janus Kinase inhibitors (JAKi) Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Company (2021-2026) Table 33. Global Janus Kinase inhibitors (JAKi) Sales by Company (2021-2026) & (K Units) Table 34. Global Janus Kinase inhibitors (JAKi) Sales Share by Company (2021-2026) Table 35. Global Janus Kinase inhibitors (JAKi) Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Janus Kinase inhibitors (JAKi) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Janus Kinase inhibitors (JAKi) Major Company Production Sites and Headquarters Table 38. Global Janus Kinase inhibitors (JAKi) Company, Product Type & Application Table 39. Global Janus Kinase inhibitors (JAKi) Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Janus Kinase inhibitors (JAKi) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Janus Kinase inhibitors (JAKi) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Janus Kinase inhibitors (JAKi) Sales by Region (2021-2026) & (K Units) Table 44. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Region (2021-2026) Table 45. Global Janus Kinase inhibitors (JAKi) Sales by Region (2021-2026) & (US$ Million) Table 46. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Region (2021-2026) Table 47. Global Janus Kinase inhibitors (JAKi) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Janus Kinase inhibitors (JAKi) Sales by Region (2027-2032) & (K Units) Table 49. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Region (2027-2032) Table 50. Global Janus Kinase inhibitors (JAKi) Sales by Region (2027-2032) & (US$ Million) Table 51. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Region (2027-2032) Table 52. Global Janus Kinase inhibitors (JAKi) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Janus Kinase inhibitors (JAKi) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (K Units) Table 55. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Application (2021-2026) Table 56. Global Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (US$ Million) Table 57. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Application (2021-2026) Table 58. Global Janus Kinase inhibitors (JAKi) Price by Application (2021-2026) & (US$/Unit) Table 59. Global Janus Kinase inhibitors (JAKi) Sales by Application (2027-2032) & (K Units) Table 60. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Application (2027-2032) Table 61. Global Janus Kinase inhibitors (JAKi) Sales by Application (2027-2032) & (US$ Million) Table 62. Global Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Application (2027-2032) Table 63. Global Janus Kinase inhibitors (JAKi) Price by Application (2027-2032) & (US$/Unit) Table 64. North America Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (K Units) Table 65. North America Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (K Units) Table 67. Europe Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (K Units) Table 71. Latin America Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (US$ Million) Table 74. Galapagos NV Company Information Table 75. Galapagos NV Business Overview Table 76. Galapagos NV Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Galapagos NV Janus Kinase inhibitors (JAKi) Product Portfolio Table 78. Galapagos NV Recent Development Table 79. AbbVie Company Information Table 80. AbbVie Business Overview Table 81. AbbVie Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. AbbVie Janus Kinase inhibitors (JAKi) Product Portfolio Table 83. AbbVie Recent Development Table 84. Pfizer Inc. Company Information Table 85. Pfizer Inc. Business Overview Table 86. Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Pfizer Inc. Janus Kinase inhibitors (JAKi) Product Portfolio Table 88. Pfizer Inc. Recent Development Table 89. Eli Lilly and Co. Company Information Table 90. Eli Lilly and Co. Business Overview Table 91. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product Portfolio Table 93. Eli Lilly and Co. Recent Development Table 94. North America Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 95. North America Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026) & (K Units) Table 96. North America Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021-2026) Table 97. North America Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032) & (K Units) Table 98. North America Janus Kinase inhibitors (JAKi) Sales Market Share Forecast by Country (2027-2032) Table 99. North America Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. North America Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026) & (US$ Million) Table 101. North America Janus Kinase inhibitors (JAKi) Market Share by Country (2021-2026) Table 102. North America Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. North America Janus Kinase inhibitors (JAKi) Market Share Forecast by Country (2027-2032) Table 104. Europe Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. Europe Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026) & (K Units) Table 106. Europe Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021-2026) Table 107. Europe Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032) & (K Units) Table 108. Europe Janus Kinase inhibitors (JAKi) Sales Market Share Forecast by Country (2027-2032) Table 109. Europe Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Europe Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026) & (US$ Million) Table 111. Europe Janus Kinase inhibitors (JAKi) Market Share by Country (2021-2026) Table 112. Europe Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Europe Janus Kinase inhibitors (JAKi) Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026) & (K Units) Table 116. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021-2026) Table 117. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032) & (K Units) Table 118. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026) & (US$ Million) Table 121. Asia-Pacific Janus Kinase inhibitors (JAKi) Market Share by Country (2021-2026) Table 122. Asia-Pacific Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Asia-Pacific Janus Kinase inhibitors (JAKi) Market Share Forecast by Country (2027-2032) Table 124. Latin America Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Latin America Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026) & (K Units) Table 126. Latin America Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021-2026) Table 127. Latin America Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032) & (K Units) Table 128. Latin America Janus Kinase inhibitors (JAKi) Sales Market Share Forecast by Country (2027-2032) Table 129. Latin America Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Latin America Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026) & (US$ Million) Table 131. Latin America Janus Kinase inhibitors (JAKi) Market Share by Country (2021-2026) Table 132. Latin America Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Latin America Janus Kinase inhibitors (JAKi) Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026) & (K Units) Table 136. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021-2026) Table 137. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032) & (K Units) Table 138. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Janus Kinase inhibitors (JAKi) Market Share by Country (2021-2026) Table 142. Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Middle East and Africa Janus Kinase inhibitors (JAKi) Market Share Forecast by Country (2027-2032) Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Janus Kinase inhibitors (JAKi) Distributors List Table 147. Janus Kinase inhibitors (JAKi) Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Janus Kinase inhibitors (JAKi) Image Figure 2. Global Janus Kinase inhibitors (JAKi) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Janus Kinase inhibitors (JAKi) Market Size (2021-2032) & (US$ Million) Figure 4. Global Janus Kinase inhibitors (JAKi) Sales (2021-2032) & (K Units) Figure 5. Upadacitinib Image Figure 6. Global Upadacitinib Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tofacitinib Image Figure 8. Global Tofacitinib Sales YoY Growth (2021-2032) & (K Units) Figure 9. Filgotinib Image Figure 10. Global Filgotinib Sales YoY Growth (2021-2032) & (K Units) Figure 11. Baricitinib Image Figure 12. Global Baricitinib Sales YoY Growth (2021-2032) & (K Units) Figure 13. Abrocitinib Image Figure 14. Global Abrocitinib Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Janus Kinase inhibitors (JAKi) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Janus Kinase inhibitors (JAKi) Market Share by Type 2025 VS 2032 Figure 17. North America Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Type in 2025 Figure 18. North America Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Type in 2025 Figure 19. Europe Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Type in 2025 Figure 20. Europe Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Type in 2025 Figure 23. Latin America Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Janus Kinase inhibitors (JAKi) Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Janus Kinase inhibitors (JAKi) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Janus Kinase inhibitors (JAKi) Market Share by Application 2025 VS 2032 Figure 37. North America Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Application in 2025 Figure 38. North America Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Application in 2025 Figure 39. Europe Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Application in 2025 Figure 40. Europe Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Application in 2025 Figure 43. Latin America Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share in Value by Application in 2025 Figure 47. North America Janus Kinase inhibitors (JAKi) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Janus Kinase inhibitors (JAKi) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Janus Kinase inhibitors (JAKi) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Janus Kinase inhibitors (JAKi) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Janus Kinase inhibitors (JAKi) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Janus Kinase inhibitors (JAKi) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Janus Kinase inhibitors (JAKi) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Janus Kinase inhibitors (JAKi) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Janus Kinase inhibitors (JAKi) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Janus Kinase inhibitors (JAKi) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Janus Kinase inhibitors (JAKi) Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Janus Kinase inhibitors (JAKi) Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Janus Kinase inhibitors (JAKi) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Upadacitinib
  • Tofacitinib
  • Filgotinib
  • Baricitinib
  • Abrocitinib
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Galapagos NV
  • AbbVie
  • Pfizer Inc.
  • Eli Lilly and Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Janus Kinase inhibitors (JAKi) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Janus Kinase inhibitors (JAKi) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Janus Kinase inhibitors (JAKi) Market by Type
  6. 1.3.1 Upadacitinib
  7. 1.3.2 Tofacitinib
  8. 1.3.3 Filgotinib
  9. 1.3.4 Baricitinib
  10. 1.3.5 Abrocitinib
  11. 1.4 Global Janus Kinase inhibitors (JAKi) Market Size by Type
  12. 1.4.1 Global Janus Kinase inhibitors (JAKi) Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Janus Kinase inhibitors (JAKi) Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Janus Kinase inhibitors (JAKi) Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Janus Kinase inhibitors (JAKi) Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Janus Kinase inhibitors (JAKi) Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Janus Kinase inhibitors (JAKi) Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Janus Kinase inhibitors (JAKi) Industry Trends
  2. 2.2 Janus Kinase inhibitors (JAKi) Industry Drivers
  3. 2.3 Janus Kinase inhibitors (JAKi) Industry Opportunities and Challenges
  4. 2.4 Janus Kinase inhibitors (JAKi) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Janus Kinase inhibitors (JAKi) Revenue (2021-2026)
  2. 3.2 Global Top Players by Janus Kinase inhibitors (JAKi) Sales (2021-2026)
  3. 3.3 Global Top Players by Janus Kinase inhibitors (JAKi) Price (2021-2026)
  4. 3.4 Global Janus Kinase inhibitors (JAKi) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Janus Kinase inhibitors (JAKi) Major Company Production Sites & Headquarters
  6. 3.6 Global Janus Kinase inhibitors (JAKi) Company, Product Type & Application
  7. 3.7 Global Janus Kinase inhibitors (JAKi) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Janus Kinase inhibitors (JAKi) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Janus Kinase inhibitors (JAKi) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Janus Kinase inhibitors (JAKi) Tier 1, Tier 2, and Tier 3
4 Janus Kinase inhibitors (JAKi) Regional Status and Outlook
  1. 4.1 Global Janus Kinase inhibitors (JAKi) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Janus Kinase inhibitors (JAKi) Historic Market Size by Region
  3. 4.2.1 Global Janus Kinase inhibitors (JAKi) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Janus Kinase inhibitors (JAKi) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Janus Kinase inhibitors (JAKi) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Janus Kinase inhibitors (JAKi) Forecasted Market Size by Region
  7. 4.3.1 Global Janus Kinase inhibitors (JAKi) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Janus Kinase inhibitors (JAKi) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Janus Kinase inhibitors (JAKi) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Janus Kinase inhibitors (JAKi) by Application
  1. 5.1 Janus Kinase inhibitors (JAKi) Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Janus Kinase inhibitors (JAKi) Market Size by Application
  6. 5.2.1 Global Janus Kinase inhibitors (JAKi) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Janus Kinase inhibitors (JAKi) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Janus Kinase inhibitors (JAKi) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Janus Kinase inhibitors (JAKi) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Janus Kinase inhibitors (JAKi) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Janus Kinase inhibitors (JAKi) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Galapagos NV
  2. 6.1.1 Galapagos NV Company Information
  3. 6.1.2 Galapagos NV Business Overview
  4. 6.1.3 Galapagos NV Janus Kinase inhibitors (JAKi) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Galapagos NV Janus Kinase inhibitors (JAKi) Product Portfolio
  6. 6.1.5 Galapagos NV Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Janus Kinase inhibitors (JAKi) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Janus Kinase inhibitors (JAKi) Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 Pfizer Inc.
  14. 6.3.1 Pfizer Inc. Company Information
  15. 6.3.2 Pfizer Inc. Business Overview
  16. 6.3.3 Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Inc. Janus Kinase inhibitors (JAKi) Product Portfolio
  18. 6.3.5 Pfizer Inc. Recent Developments
  19. 6.4 Eli Lilly and Co.
  20. 6.4.1 Eli Lilly and Co. Company Information
  21. 6.4.2 Eli Lilly and Co. Business Overview
  22. 6.4.3 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product Portfolio
  24. 6.4.5 Eli Lilly and Co. Recent Developments
7 North America by Country
  1. 7.1 North America Janus Kinase inhibitors (JAKi) Sales by Country
  2. 7.1.1 North America Janus Kinase inhibitors (JAKi) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026)
  4. 7.1.3 North America Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Janus Kinase inhibitors (JAKi) Market Size by Country
  6. 7.2.1 North America Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026)
  8. 7.2.3 North America Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Janus Kinase inhibitors (JAKi) Sales by Country
  2. 8.1.1 Europe Janus Kinase inhibitors (JAKi) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026)
  4. 8.1.3 Europe Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Janus Kinase inhibitors (JAKi) Market Size by Country
  6. 8.2.1 Europe Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Janus Kinase inhibitors (JAKi) Sales by Country
  2. 9.1.1 Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Janus Kinase inhibitors (JAKi) Market Size by Country
  6. 9.2.1 Asia-Pacific Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Janus Kinase inhibitors (JAKi) Sales by Country
  2. 10.1.1 South America Janus Kinase inhibitors (JAKi) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026)
  4. 10.1.3 South America Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Janus Kinase inhibitors (JAKi) Market Size by Country
  6. 10.2.1 South America Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026)
  8. 10.2.3 South America Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country
  2. 11.1.1 Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size by Country
  6. 11.2.1 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Janus Kinase inhibitors (JAKi) Value Chain Analysis
  2. 12.1.1 Janus Kinase inhibitors (JAKi) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Janus Kinase inhibitors (JAKi) Production Mode & Process
  7. 12.2 Janus Kinase inhibitors (JAKi) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Janus Kinase inhibitors (JAKi) Distributors
  10. 12.2.3 Janus Kinase inhibitors (JAKi) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst